Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Fort Myers. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in Fort Myers at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combination with trastuzumab and chemotherapy as first-line treatment in patients with HER2-positive locally advanced/metastatic adenocarcinoma of the gastric and/or gastroesophageal junction (G/GEJ).Eligible subjects will be randomized to the two groups based on a 1:1 ratio. Enrolled subjects shall be treated with the study drug until the loss of clinical
Sponsor: Shanghai Henlius Biotech
Check if you qualify for this gastric cancer clinical trial in Fort Myers, FL
If you're searching for gastric cancer treatment options in Fort Myers, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fort Myers research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.